fashion -WSS

fashion

author：hotspot 2025-09-29 01:08:11 - browse：39

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Sage considers ways to reduce costs following FDA rejection

WSS

Election results set back Medicaid expansion plans

Readout Newsletter: BridgeBio, Akero, and human embryo models

Stem cell biologist probes earliest stages of human development

$1 billion proposal to grow Boston, Massachusetts biotech

Google's generative AI to analyze medical images — and talk to docs

Streamlined flu vaccines recommended by FDA advisory panel

hotspot

fashion

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Flash flood warnings continue for parts of Missouri, Illinois

Dobbs anniversary: the lost opportunity of abortion as health care

With heat waves through August, officials warn of health risks

Hollywood unions extend contract negotiations for actors

Florida health officials providing scant details on measles cases

How to save PrEP access — and even expand it

A new approach to psychiatric drug development

At least 13 dead in Texas as scorching temps continue

Flash flood warnings continue for parts of Missouri, Illinois

focus

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

State of the Union pitch: Bigger Medicare drug price negotiations

Streamlined flu vaccines recommended by FDA advisory panel

He's 19 months old and has one of the world’s rarest diseases

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Failure, not just success, should guide future doctors

Wikipedia

hotspot

focus

Wikipedia